>PROKKA_00001 Clostridium P-47 protein
MNNLKPFIYYDWEKTILKNTKENYSINEIIPKTFFMELHGTKITNSTLNGTWKSWNLTNE
GEGSYPVLKCIIDDGYLDMNFGASSEKIPLKNVWIKLCMKINPNSDGTYSIPEKSSSFYI
KDNSLKISKDNLILDKYLNKLMLSYFKNNIKNIEMFINKSRIQTKVVGDLSLLGWNTENS
VSFRTMNEFIKKDNLYPKDFKAVYSYRKMTFTATGTFDSWEMTTGADGRNIRFKCPIKYA
VYDLDGDVFNSSTENFLLIQVDLTYFDSKTTINDPTGENDGKQFNLKIKTNDDKLKNVLI
VTYNLTDTDGSMSSEDKDFLSLAFRNWFNENIQQFEQIFAYILLDETAKIPEYQWLKPTQ
ISYGSASVETANDEPDLDASIFSAMSMVENNTNSTPSHAVDNRMLQLTKTQAAFGISFPL
FIEHFLKQALLSSQFISVDDIVADINTLTITNNKQIIFGKVENSDGKNVDSSLKPGKLKL
SLQNNLIVLELFDLTWEQGRGVTGHFDFRQEYELALESKSGKQIPILKVHDEPEIEYYVE
EAQWKTNEDMIVSAVVGTVFSMILGASMKLAGSALSKAGKLIRSKATTIKGRKKIYINRS
NVRQLRKDSGVTEIELERINRRNSSIAAEDARLISNNGTTSIQTLGDMKKKPMSTGQRIA
IGAKKIAGTAVMFGAVGLGMNFGEMLINYINAMENNDYSAIPGINSFMQQCIGAMQWPDK
DSELKVTFSKLQGIYLLGGTLEKNNKTDNK*
>PROKKA_00002 hypothetical protein
MKQTFPFNFDDALLNTGGSIHLEKVNQNCSPNYQYFKIKFIEGYLHIKNKSGDILEKYDL
KDLISLIALKKDYLKLSPLNNKKPKEFTNIKNKHLENRFNLYVINEDINGKITKNGILEE
IILNRLLLSIFLENEENLLQIA*
>PROKKA_00003 RNA polymerase factor sigma-70
MKNLFFLMNTLKDDNEKFKKIYMNYKDLIDIFTTKYNLSENYNDILNHFWIILKKADLNK
FNTEDDLNKYISKCLKRYCLSICMKKNRDKKIIYNSEITDINLNLIQDNCFNDIEFEFKD
LISILPNTQKNIIYMKFFKDMKDIEIAKKLKISRQSVYKNKNLALEKLKPILKELINI*
>PROKKA_00004 Clostridium P-47 protein
MNTYGWDIVYGCSKRVVNKHLEDYITKNKVEFLYSNTDKKQEIKMVFDNWEIINGGSSNF
LRIKTPIKEGYFKVKNTTIDLSGVNPVLEIKLDFFNDISNPNIKKLKFNFGSESNDDIKI
IVSDLNGKLQEEDEFYFNKLLINAFIQNEKQISYIFASLNVTSDIEWMNPKQFKFVYYSP
TDNSDGYLFILSVVTNRDISELSVNVDGNILGNNSEVGLLISEKLFLKNLVLPKLSSNMG
SDITSNNFKVISTSDTTGRIANNSTLNWYGIKVGLIWYYPKINNFSMELFEGNKLKTKLS
GIVRLTGYERIYSELNLECTTKFIYDPKNKKASFEYYKTSIMSCRPIFGLLDGVPALVAK
SVGDWSLKSFRNSLAFGLTNNFTDIINGIVRWNNLKISEVTNVTLNVGFCIQGNAN*
>PROKKA_00005 Tetanus toxin precursor
MKINNNFNIDSPVDNKDVAIVRGRKTDIFLKVFQVAPNIWVAPERYYGESLNINEDQKSN
GGIYDSNFLLTNDEKDEFLQATVKILQRINNNVIGAKLLSLISTAIPFPYEYRAEDYRQT
NYLSSKDNQHYYTANLVIFGPGTNIVENNVVYYKKEDSKNGMGTMSEIWFQPFLTYKYDQ
FYVDPALELIKCLIKSLYYLYGIKPNDDLSIPYRLRSEFNSLEYSELDMVDFLISGGTDY
KLLNTNPYWFTDNYFINAPKNFEKYKNDYETKIKNNNDIANSIKLYLEQKFKTNVQDIWE
LNLSYFSTEFEIMMPEIFNNALNHYHRKEYYVIDYFKNYNINGFINGQIKTILPLSKYNK
NIINKPELIVNLINENNSVLMKSNIYGDGLKDTIGNFYAVYKIPYNIGDEYHINSSDSCL
DNVDIKEIDNIPPINDADIYPYRKNCDPFTPVYNITETKEINTTIPFPVNYLQAQVTNSN
DINLSSDFLKVISSKDRSLVYSFLDNTIDYLDSIKYDGPIDTDKKYYLWLREIFRNYSFD
ITATQEINTDCGINKVVTWFGKALNILNTSDSFVEEFQNLGPISLINKKENLSMPKIEID
EIPNSMLNLSFKDLSENLFNIFSKNNSYFEKIYYDFLDQWWTQYYSQYFDLICMAKRSVL
AQESLIKKIIQKKLSYLIGNSNISSDNLALMNLTTTNTLRDISNESQIAMNNVNNFLNNV
AICVFQTNIYPKFISFMEQCINNINKNTREFIQKCTNITENEKLQLINQNIFSSLDFDFL
NIENLKSLFNSETGLLIKEETSPYELVLYAFQEPGNNAIGDASGKNTSIEYSKDIGLVYG
INSDALYLNGSNQSISFSNDFFENGLTNSFSIYFWLRNLGKDTIKSKLIGSKEDNCGWEI
YFQDTGLVFNMIDSNGNEKNIYLSDVSNNSWHYITISVDRLKEQLLIFIDDNLVANESIK
EILNIYSSNTISLVNENNPIYVEGLSILNKPTTSQEVLSNYFKVLNNSYIRDSSEERLEY
NKTYQLYNYVFSENPIYEIKQNNNIYLTINNTNNLNLQVSKFKLLSINPNKQYVQKLDEV
IISVLDNMEKYIDISEDNRLQLIDNKNNAKKMIISNDIFISNCLIISYNGKYICLSMKDE
NHNWMICNNDMSKYLYLWSFK*
>PROKKA_00006 Botulinum neurotoxin type A precursor
MQFVNKQFNYKDPVNGVDIAYIKIPNVGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLN
PPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGG
STIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHEVLNLTRNGY
GSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAGHRLYGIAINPN
RVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDIASTLNKA
KSIVGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVKFFKV
LNRKTYLNFDKAVFKINIVPKVNYTIYDGFNLRNTNLAANFNGQNTEINNMNFTKLKNFT
GLFEFYKLLCVRGIITSKTKSLDKGYNKALNDLCIKVNNWDLFFSPSEDNFTNDLNKGEE
ITSDTNIEAAEENISLDLIQQYYLTFNFDNEPENISIENLSSDIIGQLELMPNIERFPNG
KKYELDKYTMFHYLRAQEFEHGKSRIALTNSVNEALLNPSRVYTFFSSDYVKKVNKATEA
AMFLGWVEQLVYDFTDETSEVSTTDKIADITIIIPYIGPALNIGNMLYKDDFVGALIFSG
AVILLEFIPEIAIPVLGTFALVSYIANKVLTVQTIDNALSKRNEKWDEVYKYIVTNWLAK
VNTQIDLIRKKMKEALENQAEATKAIINYQYNQYTEEEKNNINFNIDDLSSKLNESINKA
MININKFLNQCSVSYLMNSMIPYGVKRLEDFDASLKDALLKYIYDNRGTLIGQVDRLKDK
VNNTLSTDIPFQLSKYVDNQRLLSTFTEYIKNIINTSILNLRYESNHLIDLSRYASKINI
GSKVNFDPIDKNQIQLFNLESSKIEVILKNAIVYNSMYENFSTSFWIRIPKYFNSISLNN
EYTIINCMENNSGWKVSLNYGEIIWTLQDTQEIKQRVVFKYSQMINISDYINRWIFVTIT
NNRLNNSKIYINGRLIDQKPISNLGNIHASNNIMFKLDGCRDTHRYIWIKYFNLFDKELN
EKEIKDLYDNQSNSGILKDFWGDYLQYDKPYYMLNLYDPNKYVDVNNVGIRGYMYLKGPR
GSVMTTNIYLNSSLYRGTKFIIKKYASGNKDNIVRNNDRVYINVVVKNKEYRLATNASQA
GVEKILSALEIPDVGNLSQVVVMKSKNDQGITNKCKMNLQDNNGNDIGFIGFHQFNNIAK
LVASNWYNRQIERSSRTLGCSWEFIPVDDGWGERPL*
>PROKKA_00007 hypothetical protein
MLISSYFNLFNIITVRKNTIFIVNTSLVVYLINDTRYHYNDFANYSFE*
>PROKKA_00008 Autolytic lysozyme
MLKGIDVSEHQGEIGWKAVKNSGIQFAILRAGYGKNNIDKQFINNANGCTSVGMPFGLYW
FSYAYTENMARKEAQYCVAQAKKYKISYPICYDLEYDTIRYANNCGVTITKSLATKMVHA
FCQEVERNGYFAMNYSNQDFLLNKFDSNLLKRYALWYAWYNNSLNRTCGIWQYSENGRVP
GIAGAAVDMNYCYLNMPGASNTSPNKNAFRGVHYLIRELQQEINSQGLGEVVVDGIAGQA
TINSAPVCKQGARGGITKVIQQMLISIGYPVGSHGVDGVFGDSTVTAIKAFQRDCHLVAD
GIVGKETWKALFRNLK*
>PROKKA_00009 hypothetical protein
MKTIRFKIVAGINEGYFHENENKNRIQIVGV*
>PROKKA_00010 Nucleoside 2-deoxyribosyltransferase
MSKRVFLAAPFKGVIKEKQSIMKEQEKKRIENLILFLEEKGWKVDNAHKREAWGANFMSP
DQCTKLDYDAIKECDLFIAFPGVPVSPGTHIEIGWASAMDKKIILLLAEKEENYAYLIRG
LHTVSNVHYIIYNEEKEYLQKLDLYLDGENNEV*
>PROKKA_00011 Thymidylate synthase 2
MKFKNFHEAYLKNLNDVYYTPEFINQPRGNVSKERLNYFMILENPRERICYTKSRKTNIV
FNFAEALWYLSGSNDLDYISYYASNMKKYSMDGKTLTGTAYGPKIFSYGHNNANQWHRIV
ELFKEDPDTKRGFIEIFDANEDLSLKNIDVSCTIGFQFFIREHKLYMTTFMRANDAYRGI
ISDVFSFTFIQEFLATELNLDIGQYSHQVATTHIYEPDFKLAEKVLCESKSVKKELSFPR
MPKKDNWEDLKIVLQYEKELRKQRIHLTKKDIDELEIDKYWKQIICLFVLYQEIYYEDNL
DYEIYESLEPLYQYLFSNKWNQYF*
>PROKKA_00012 ubiquinone/menaquinone biosynthesis methyltransferase
MESIFLGGNILGTCWKDEGVSKKFNLYNDMLENILGFDYIFENLKSNESIKKILDFGCGP
GKVAERMAKIKPESQIIAVDQSQNMLDIAMKEHNKENIDYKLIEQNQLKEIEKNSIDCVV
LCFVIINNSDKDRIKTIFQEIFRVLKKGRKFFILDSNPNAAGVEFSTFTNGKSGQAYHLG
DHKKQFLKIPNNEVLILEDYYWPIDFYINNLEAVGFENYKIVEPTIEKINKPDLNAIEKT
YDIECWGSEKNKPPFIIFDVEK*
>PROKKA_00013 Thiaminase-1 precursor
MKLKNLFKRSLSLLFSFIMIFTLVSGLNVKAFSGDEPKQTLNVALYEYVPDPIRFKKAVE
TEWNKKEPNIKLNFVDWDCYSEDPPKDLDVFVFDAIYLSHFVKEGYLSEIPEKDIKNKED
ILPFAMEGCTIKGSAYAIPQIICTNLLFSRKGDSDIQNINSVFDLNDKLGKNTSEDIIPP
ENKGLLIDMSGGTSKACMYLDSLIDTTQEYTKFCSLPNLNELNKDAIESLVLLQSMAGKS
QANYWPENNDSYIRAKWFINGKGRAYIGYTEAMSQMKEFANDIDFKTISLSKNSNIPIFY
GDVAGINSSITNSYKKEKAIELANIITDKNTMVNAVSPDENNKYPQYLLPARRSVYHNLE
NKYPIYGKLYKIADNSNNKLFRTGPEIREWLKQAKKIITEYLQQ*
>PROKKA_00014 Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase
MKKVLSIAGSDCSGGAGIQADLKTFSAHGVFGMSVIVSVVAENTSRVIDIQDVTPDMIKS
QIDAVYEDIGTDAVKIGMLSTPDCMKAVSEKLQEYKPKNVVIDPVMYAKNGCPLMDPNSV
STLIQSIIYHADILTPNIPEAERISGYKIKTLEDMEKAAGIIEGMGCKSVLIKGGHYIGD
AVDVLYDGNKFYHYKTQRIHTKNTHGTGCTLSSAIASNLALGFEINEAVKRAKNYITMAI
EHSLEIGKGNGPTNHFYQVYLNGLKGMELDNHTRS*
>PROKKA_00015 hypothetical protein
MRKVYKNPKELATCLKDLVDLYFEDLMTYEKLEEKVSKIVEANKDSIYKNGVINTKLANV
LGDLRIDVINKIVKEK*
>PROKKA_00016 putative membrane protein
MTKYAIVFFMSMVPIVELRGAIPYSQMYNLPLLQSFIVAIIGNMLPMPFIYLFARKVLVW
GADKPITGKFFTWCLEKGEKAGKKLQEKTGKKGLFWGLLIFVAIPAPGTGAWTGTLAASL
LDMDFKTSILAVMLGVLVAGVIMGTASVGLFSFF*
>PROKKA_00017 putative ABC transporter ATP-binding protein YxlF
MDKPNDVVVSIRNLKMSYGSKEVLKGINLDVNKGEIIGYIGPNGAGKSTTVKIMLGLVKG
YEGEVKIFGNNISYENVEYKHKIGYVPENGEIYDNLTAYEYITFLGEIYGMELKEVNNKA
KKLMSLFGIKEAYHSRISSYSKGMRQKLLIISSLIHNPDILFLDESLSGLDANSVLVFKE
VLSKLASEGKTIFYSSHIMEVVEKISSRIILLNNGQIAADGTFEELKKKNMEGSLEQIFN
QITGFTKHEEIANEFISILKEV*
>PROKKA_00018 hypothetical protein
MIKNIMAPIFILIFTIIGDGIKIKTARKTPINPYRNSDFLKVFFLFSFSLSLYIVGTLLL
SIKSFNLSIVLMEA*
